126 Relationship Between Complement Factors and CC Chemokines and the Pharmacokinetics (PK) and Pharmacodynamics (PD) of PEGylated Liposomal Doxorubicin (PLD) in Patients with Refractory Epithelial Ovarian Cancer (EOC)

作者： G. Song , S. Moore , T. Tarrant , M. Dobrovolskaia , D. Barrow

DOI: 10.1016/S0959-8049(12)71924-X

关键词: